Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the non-inferiority of ritonavir-boosted GS-9137
relative to a ritonavir-boosted Comparator Protease Inhibitor when used as part of
combination antiretroviral regimens in subjects who have failed, or are failing, protease
inhibitor therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Gilead Sciences
Treatments:
HIV Integrase Inhibitors HIV Protease Inhibitors Integrase Inhibitors Protease Inhibitors Ritonavir